Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Weightwatchers International Inc.

Fed Chair Jerome Powell said the central bank could raise rates more than expected if economic data remain strong.

Stock Market Today: Blue Chip Stocks Lead Market Lower After Powell Speech

Johnson & Johnson

Visa

The Dow Jones Industrial Average was the top-performing major U.S. stock index in 2022. The Dow is composed of 30 generally profitable, time-tested businesses, which means it's packed with stocks that can outperform during a bear market.

3 Dow Stocks That Are Screaming Buys in March

DEERFIELD, Ill.--(BUSINESS WIRE)--We want to be very clear about what our position has always been: Walgreens plans to dispense Mifepristone in any jurisdiction where it is legally permissible to do so. Once we are certified by the FDA, we will dispense this medication consistent with federal and state laws. Providing legally approved medications to patients is what pharmacies do, and is rooted in our commitment to the communities in which we operate.

Walgreens Statement on Mifepristone

Walgreens Boots' (WBA) comparable pharmacy sales decline, reflecting lower demand for COVID-19 services.

Walgreens Boots (WBA) Benefits From New Launches Amid FX Woes

Automatic Data Processing

Amgen

Best Buy

Blackstone Group

CME Group

ConocoPhillips

CVS Health

Enterprise Products Partners

Home Depot

Intercontinental Exchange

Intel

Kroger

Lowe's

PepsiCo

Prudential Financial

Phillips 66

Tractor Supply

Williams-Sonoma

Cash is yielding over 4%, so a dividend growth investor can afford to be patient. February marked the first monthly decline in projected income since 2016 due to dividend cuts.

My Dividend Growth Portfolio February Update: Cash Is Not Trash

VillageMD, the developer of doctor practices and clinics backed by Walgreens, has acquired a big medical group in Connecticut with 30 locations across the state.

Walgreens-Backed VillageMD Buys 30-Location Physician Group In Connecticut

Chevron

Dow Inc

Verizon

Fourth-quarter earnings reporting is all but over, and many across Wall Street are watching the quick move higher in interest rates with a high level of anxiety.

High Time to Move Money to These 5 Highest-Yielding Dow Stocks

Walgreens (WBA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Will Walgreens (WBA) Beat Estimates Again in Its Next Earnings Report?

DEERFIELD, Ill.--(BUSINESS WIRE)--WBA will release its fiscal 2023 second quarter results at 7 a.m. ET Tuesday, March 28, 2023.

Walgreens Boots Alliance Schedules Fiscal 2023 Second Quarter Earnings Announcement for March 28, 2023

DoorDash

Uber

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens, in partnership with DoorDash and Uber, today announced free, Same Day Rx Delivery of medications for the prevention and treatment of HIV. This service is available to eligible patients within 15 miles of thousands of participating Walgreens retail pharmacies nationwide. “While most of the U.S.

Walgreens, DoorDash and Uber Team Up to Launch Free, Same Day Rx Delivery of HIV Medications

Option Care Health

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold 13.0 million shares of Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH) common stock in an underwritten secondary offering and, subject to completion of the offering, a concurrent share repurchase by OPCH in the amount of approximately 2.5 million shares.

Walgreens Boots Alliance Sells 15.5 Million Shares of Option Care Health

Carlisle Companies

McDonald's

Medtronic

MGE Energy

RPM International

Sherwin-Williams

Telephone and Data Systems

But today, we are serving up the main course with these 11 stocks well on their way to becoming dividend kings. We have ordered this list by how many consecutive years these companies have grown their dividends.

These 11 stocks will be Dividend Kings in 5 years or less.

AllianceBernstein Hld

Amazon

Ensign Group

Tanger Factory Outlet Centers

Welltower

Under a similar principle to gravity (what goes up must come down), targeting baby boomer stocks to buy aligns with harsh realities: those who are born into this planet eventually get older. Yes, even millennials and Generation Z will at some point be yelling at kids to get off their lawn.

7 Top Stocks to Buy to Play the Aging Baby Boomer Trend

Abbott Labs

Clorox

Ecolab

Essex Property Trust

McCormick

Nordson

Realty Income Corp

J. M. Smucker

S&P Global

Stanley Black & Decker

Sysco

T. Rowe Price Group

V.F.

West Pharmaceutical Services

NOBL started the year off with a gain of 3.23% in January; it is thus far not faring as well in February, but the ETF is still positive year-to-date. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term.

My Best Dividend Aristocrats For March 2023

AbbVie

Cardinal Health

One of the best ways for investors to save for the future and retirement is to consistently invest money into tax-sheltered vehicles, whether it be a 401(k) plan or self-directed individual retirement account (IRA).

7 ‘Strong Buy' 2023 Dividend Aristocrats to Buy Now and Hold Forever in Your IRA

Altria

Are these dividend stocks on your watchlist today?

Best Stocks To Buy Now? 2 Top Dividend Stocks In Focus

In the 2020s, Walgreens Boots Alliance (NASDAQ: WBA ) is set become more than just your average drugstore. The company has broader ambitions, including a major venture into primary healthcare.

Can Walgreens (WBA) Stock Soar 20% From Here? Why This Analyst Thinks So.

Walgreens Boots (WBA) raises its U.S. Healthcare target, including fiscal 2025 sales goal.

Walgreens' (WBA) New Partnerships Aid, Margin Pressure Ails

Rosalind Brewer is shifting the chain's focus to medical clinics.

Walgreens CEO Bets on Doctors Over Drugstores in Search for Growth

Blue-chip pharma stock Walgreens Boots Alliance Inc (NASDAQ:WBA) has been consolidating above the $35 level for the past month or so, and was recently rejected by the $38 level.

5 Reasons to Steer Clear From Walgreens Stock

News for Walgreens Stock (WBA)